Dogwood Therapeutics, Inc. Share Price
NASDAQ: DWTX | Micro CapDogwood Therapeutics, Inc. Stock Performance
Open $2.02 | Prev. Close $1.83 | Circuit Range N/A |
Day Range $1.96 - $2.02 | Year Range $1.33 - $9.50 | Volume 490 |
Average Traded $1.98 |
Dogwood Therapeutics, Inc. Share Price Today
As of 13 August 2026, Dogwood Therapeutics, Inc.'s share price is $1.89. The stock opened at $2.02, compared to its previous close of $1.83. During today's trading session, Dogwood Therapeutics, Inc.'s share price traded between $1.96 and $2.02, with an average price of $1.99. Over the past 52 weeks, the stock has recorded a high of $9.50 and a low of $1.33. In terms of performance, Dogwood Therapeutics, Inc.'s share price has declined by 32.14% over the last six months and is down 61.19% on a year-on-year basis.
Dogwood Therapeutics, Inc. Share Price Chart
Dogwood Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $9.41M | PE Ratio (TTM) -0.27 | Dividend Yield N/A |
EPS (TTM) $-7.13 | Revenue (TTM) N/A | Return On Equity (TTM) -45.74% |
Profit Margin N/A | Debt to Equity 0.04 | Quarterly Earnings Growth YoY -590.35% |
Dogwood Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Dogwood Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a fixed dose combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for burn and ocular pain; and IMC-2, a combination of valacyclovir and celecoxib in Phase 2 clinical trial for the treatment of long-COVID and post-acute sequelae of COVID-19 infection. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was incorporated in 2012 and is based in Alpharetta, Georgia.
Dogwood Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.68 | $1.96 | +20.99% |
Jul 2026 | $1.57 | $1.62 | -1.82% |
Jun 2026 | $1.69 | $1.65 | -1.20% |
May 2026 | $1.49 | $1.67 | +18.44% |
Apr 2026 | $2.35 | $1.41 | -30.51% |
Mar 2026 | $2.92 | $2.03 | -27.15% |
Feb 2026 | $2.79 | $2.79 | -2.28% |
Jan 2026 | $4.17 | $2.85 | -31.49% |
Dec 2025 | $6.18 | $4.16 | -35.00% |
Nov 2025 | $6.04 | $6.40 | +0.16% |
Oct 2025 | $8.09 | $6.39 | -17.01% |
Sep 2025 | $4.95 | $7.70 | +58.11% |
DWTX Share Price FAQs
What is Dogwood Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Dogwood Therapeutics, Inc. stock?
What is DWTX's market capitalisation today?
What is DWTX's net income for the last quarter?
What is the 5 year returns of DWTX?
What is the high & low stock price of DWTX today?
Can I buy DWTX shares in India?